UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients

Transplantation proceedings, 2003-06, Vol.35 (4), p.1292-1294

2003

Volltextzugriff (PDF)

Dyslipidemia can reduce the immunosuppressive effects of cyclosporine

Transplant immunology, 2008-02, Vol.18 (4), p.349-351

2008

Volltextzugriff (PDF)

C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients

Transplantation proceedings, 2001-11, Vol.33 (7), p.3133-3136

2001

Volltextzugriff (PDF)

Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe

Transplantation proceedings, 2001-05, Vol.33 (3), p.2134-2135

2001

Volltextzugriff (PDF)

Long-term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction

Transplantation proceedings, 2003-12, Vol.35 (8), p.2894-2898

2003

Volltextzugriff (PDF)

Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi’s sarcoma in kidney transplant recipients

Transplantation proceedings, 2000-05, Vol.32 (3), p.526-527

2000

Volltextzugriff (PDF)

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function

Transplant international, 2000-06, Vol.13 (S1), p.S306-S310

2000

Volltextzugriff (PDF)

Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients

Transplantation proceedings, 2002-08, Vol.34 (5), p.1740-1742

2002

Volltextzugriff (PDF)

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function Transplant Int (2000) 13 [Suppl 1]: S306–S310

Transplant international, 2000, Vol.13 (6), p.456-461

2000

Volltextzugriff (PDF)

Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up

Transplantation proceedings, 2002-08, Vol.34 (5), p.1685-1686

2002

Volltextzugriff (PDF)

Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation

Transplantation proceedings, 1998-08, Vol.30 (5), p.1688-1690

1998

Volltextzugriff (PDF)

Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France

Transplantation, 2005-12, Vol.80 (12), p.1699

2005

Volltextzugriff (PDF)

Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy

Cancer detection and prevention, 2002-01, Vol.26 (4), p.292-298

2002

Volltextzugriff (PDF)

Abbreviated three-point kinetic profile in the 12-hour area under the curve for pharmacokinetic monitoring of cyclosporine

Transplantation proceedings, 1994-10, Vol.26 (5), p.2807-2808

1994

Volltextzugriff (PDF)

High Cytokine Serum Levels in Patients with Autoimmune Hemolytic Anemia (AIHA)

Immunological investigations, 1994-01, Vol.23 (6-7), p.449-456

1994

Volltextzugriff (PDF)

Verapamil improves Sandimmune Immunosuppression, reducing acute rejection episodes

Transplantation proceedings, 1996-08, Vol.28 (4), p.2174-2176

1996

Volltextzugriff (PDF)

HHV8 in renal transplant recipients

Transplant international, 2000, Vol.13 Suppl 1 (7), p.S410-S412

2000

Volltextzugriff (PDF)

Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups

Methods in molecular biology (Clifton, N.J.), 2009, Vol.471, p.409

2009

Volltextzugriff (PDF)

Long-Term predictive value of cyclosporine microemulsion C 2 level for chronic renal allograft dysfunction

Transplantation proceedings, 2003-12, Vol.35 (8), p.2894-2898

2003

Volltextzugriff (PDF)

Cyclosporine inhibits interleukin-2 production during human cellular immune response to pig antigens

Transplantation proceedings, 1994-10, Vol.26 (5), p.2869-2870

1994

Volltextzugriff (PDF)

Kinetics of cellular immune response to pig antigens in man

Transplantation proceedings, 1994-06, Vol.26 (3), p.1393-1394

1994

Volltextzugriff (PDF)

Detection of targets of human preformed natural antibodies

Transplantation proceedings, 1992-04, Vol.24 (2), p.437-438

1992

Volltextzugriff (PDF)

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD 4 function Transplant Int (2000) 13 [Suppl 1]: S306–S310

Transplant international, 2000-11, Vol.13 (6), p.456-461

2000

Volltextzugriff (PDF)

RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro

Immunology and cell biology, 2005-02, Vol.83 (1), p.25-32

2005

Volltextzugriff (PDF)

Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens

Transplantation proceedings, 2004-04, Vol.36 (3), p.698-699

2004

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(44)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(36)
Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Immunology
(25)
Transplantation
(22)
Surgery
(21)
Biological And Medical Sciences
(20)
Kidney Transplantation - Immunology
(15)
Medical Sciences
(15)
Adult
(14)
Immunomodulators
(13)
Pharmacology. Drug Treatments
(13)
Female
(11)
Male
(11)
Immunosuppressive Agents - Therapeutic Use
(10)
Middle Aged
(10)
Animals
(8)
T-Lymphocytes - Immunology
(8)
Cyclosporine - Therapeutic Use
(7)
Transplantation, Homologous
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients

Dyslipidemia can reduce the immunosuppressive effects of cyclosporine

C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients

Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe

Long-term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction

Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi’s sarcoma in kidney transplant recipients

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function

Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD4 function Transplant Int (2000) 13 [Suppl 1]: S306–S310

Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up

Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation

Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France

Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy

Abbreviated three-point kinetic profile in the 12-hour area under the curve for pharmacokinetic monitoring of cyclosporine

High Cytokine Serum Levels in Patients with Autoimmune Hemolytic Anemia (AIHA)

Verapamil improves Sandimmune Immunosuppression, reducing acute rejection episodes

HHV8 in renal transplant recipients

Cancer cohort consortium approach: cancer epidemiology in immunosuppressed groups

Long-Term predictive value of cyclosporine microemulsion C 2 level for chronic renal allograft dysfunction

Cyclosporine inhibits interleukin-2 production during human cellular immune response to pig antigens

Kinetics of cellular immune response to pig antigens in man

Detection of targets of human preformed natural antibodies

Rational design of biologically active peptides: inhibition of T cell activation through interference with CD 4 function Transplant Int (2000) 13 [Suppl 1]: S306–S310

RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro

Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens

Suchergebnisse filtern